{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:13:06Z","timestamp":1788779586218,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T00:00:00Z","timestamp":1361491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The determination of sensitive chemotherapy drugs for gastric cancer (GC) is one of the greatest challenges of adjuvant therapy. Here we evaluated the chemosensitivity of GC to anticancer drugs and the telomerase reverse transcriptase (hTERT) mRNA expression, and investigated the relationship of them.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The GC cells which were collected from 68 patients with primary GC were primary cultured. The chemosensitivity of GC cells to anticancer drugs was evaluated successfully using the MTT assay for 60 cases of GC cells, and the hTERT mRNA expression was examined in 60 cases of GC tissues and corresponding normal gastric mucosa and 6 cases of chronic superficial gastritis mucosa by in situ hybridization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Taxol, Cisplatin and 5-Fluorouracil were in general more effective than Adriamycin and Mitomycin for GC cells, and the chemosensitivity to anticancer drugs was associated with tumor histological types and a worse tumor grade. Compared to normal gastric mucosa tissues, hTERT mRNA expression was significantly increased in GC (<jats:italic>P<\/jats:italic>&lt;0.05), which was related with a worse differentiation and drug-resistance to 5-Fluorouracil or Adriamycin in GC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These data demonstrate for the first time that examinations of hTERT mRNA expression as an important factor could be used to select the chemotherapeutic drugs for GC patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Virtual slides<\/jats:title>\n            <jats:p>The virtual slide(s) for this article can be found here: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.diagnosticpathology.diagnomx.eu\/vs\/1793217009875483\" ext-link-type=\"uri\">http:\/\/www.diagnosticpathology.diagnomx.eu\/vs\/1793217009875483<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1746-1596-8-33","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T19:21:37Z","timestamp":1361560897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer"],"prefix":"10.1186","volume":"8","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Cheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,22]]},"reference":[{"issue":"11","key":"716_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1349-7006.2006.00290.x","volume":"97","author":"N Hamajima","year":"2006","unstructured":"Hamajima N, Naito M, Kondo T, Goto Y: Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci. 2006, 97 (11): 1129-1138. 10.1111\/j.1349-7006.2006.00290.x.","journal-title":"Cancer Sci"},{"issue":"7","key":"716_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4251\/wjgo.v4.i7.156","volume":"4","author":"S Nagini","year":"2012","unstructured":"Nagini S: Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol. 2012, 4 (7): 156-169. 10.4251\/wjgo.v4.i7.156.","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"716_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.amjsurg.2003.12.014","volume":"187","author":"J Chipponi","year":"2004","unstructured":"Chipponi J, Huguier M, Pezet D, Basso N, Hay JM, Quandalle P, Jaeck D, Fagniez PL, Gainant A: Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg. 2004, 187 (3): 440-445. 10.1016\/j.amjsurg.2003.12.014.","journal-title":"Am J Surg"},{"issue":"3","key":"716_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2165\/00003495-200868030-00004","volume":"68","author":"K Field","year":"2008","unstructured":"Field K, Michael M, Leong T: Locally advanced and metastatic gastric cancer: current management and new treatment developments. Drugs. 2008, 68 (3): 299-317. 10.2165\/00003495-200868030-00004.","journal-title":"Drugs"},{"issue":"1","key":"716_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1470-2045(09)70160-3","volume":"11","author":"BB Ma","year":"2010","unstructured":"Ma BB, Hui EP, Mok TS: Population-based differences in treatment outcome following anticancer drug therapies. Lancet Oncol. 2010, 11 (1): 75-84. 10.1016\/S1470-2045(09)70160-3.","journal-title":"Lancet Oncol"},{"issue":"1","key":"716_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbrc.2012.04.110","volume":"422","author":"Y Li","year":"2012","unstructured":"Li Y, Huang W, Huang S, Du J, Huang C: Screening of anti-cancer agent using zebrafish: comparison with the MTT assay. Biochem Biophys Res Commun. 2012, 422 (1): 85-90. 10.1016\/j.bbrc.2012.04.110.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"716_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.acthis.2012.01.006","volume":"114","author":"JC Stockert","year":"2012","unstructured":"Stockert JC, Blazquez-Castro A, Canete M, Horobin RW, Villanueva A: MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochem. 2012, 114 (8): 785-796. 10.1016\/j.acthis.2012.01.006.","journal-title":"Acta Histochem"},{"issue":"2B","key":"716_CR8","first-page":"1433","volume":"26","author":"R Nakamura","year":"2006","unstructured":"Nakamura R, Saikawa Y, Kubota T, Kumagai A, Kiyota T, Ohashi M, Yoshida M, Otani Y, Kumai K, Kitajima M: Role of the MTT chemosensitivity test in the prognosis of gastric cancer patients after postoperative adjuvant chemotherapy. Anticancer Res. 2006, 26 (2B): 1433-1437.","journal-title":"Anticancer Res"},{"issue":"41","key":"716_CR9","doi-asserted-by":"publisher","first-page":"34455","DOI":"10.1074\/jbc.M112.394767","volume":"287","author":"AN Sexton","year":"2012","unstructured":"Sexton AN, Youmans DT, Collins K: Specificity requirements for human telomere protein interaction with telomerase holoenzyme. J Biol Chem. 2012, 287 (41): 34455-34464. 10.1074\/jbc.M112.394767.","journal-title":"J Biol Chem"},{"issue":"11","key":"716_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1101\/gad.195339.112","volume":"26","author":"V Lundblad","year":"2012","unstructured":"Lundblad V: Telomere end processing: unexpected complexity at the end game. Genes Dev. 2012, 26 (11): 1123-1127. 10.1101\/gad.195339.112.","journal-title":"Genes Dev"},{"key":"716_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1746-1596-7-147","volume":"7","author":"H Liu","year":"2012","unstructured":"Liu H, Liu S, Wang H, Xie X, Chen X, Zhang X, Zhang Y: Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer. Diagn Pathol. 2012, 7: 147-10.1186\/1746-1596-7-147.","journal-title":"Diagn Pathol"},{"issue":"2","key":"716_CR12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.32607\/20758251-2012-4-2-44-61","volume":"4","author":"MP Rubtsova","year":"2012","unstructured":"Rubtsova MP, Vasilkova DP, Malyavko AN, Naraikina YV, Zvereva MI, Dontsova OA: Telomere lengthening and other functions of telomerase. Acta Naturae. 2012, 4 (2): 44-61.","journal-title":"Acta Naturae"},{"issue":"5","key":"716_CR13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/carcin\/bgh296","volume":"26","author":"JW Shay","year":"2005","unstructured":"Shay JW, Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 2005, 26 (5): 867-874.","journal-title":"Carcinogenesis"},{"key":"716_CR14","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2741\/4044","volume":"17","author":"C Frias","year":"2012","unstructured":"Frias C, Pampalona J, Genesca A, Tusell L: Telomere dysfunction and genome instability. Front Biosci. 2012, 17: 2181-2196. 10.2741\/4044.","journal-title":"Front Biosci"},{"key":"716_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1746-1596-7-124","volume":"7","author":"H Ozer","year":"2012","unstructured":"Ozer H, Yenicesu G, Arici S, Cetin M, Tuncer E, Cetin A: Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors. Diagn Pathol. 2012, 7: 124-10.1186\/1746-1596-7-124.","journal-title":"Diagn Pathol"},{"key":"716_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1746-1596-7-34","volume":"7","author":"Y Liu","year":"2012","unstructured":"Liu Y, Dong XL, Tian C, Liu HG: Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx. Diagn Pathol. 2012, 7: 34-10.1186\/1746-1596-7-34.","journal-title":"Diagn Pathol"},{"issue":"1","key":"716_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00042737-200301000-00013","volume":"15","author":"J Nowak","year":"2003","unstructured":"Nowak J, Januszkiewicz D, Lewandowski K, Nowicka-Kujawska K, Pernak M, Rembowska J, Nowak T, Wysocki J: Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients. Eur J Gastroenterol Hepatol. 2003, 15 (1): 75-80. 10.1097\/00042737-200301000-00013.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"716_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.canlet.2005.09.005","volume":"240","author":"KY Chen","year":"2006","unstructured":"Chen KY, Lee LN, Yu CJ, Lee YC, Kuo SH, Yang PC: Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer. Cancer Lett. 2006, 240 (1): 148-156. 10.1016\/j.canlet.2005.09.005.","journal-title":"Cancer Lett"},{"issue":"3","key":"716_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/CEJ.0b013e3282b71f0d","volume":"17","author":"SM Yang","year":"2008","unstructured":"Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP: Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Eur J Cancer Prev. 2008, 17 (3): 209-217. 10.1097\/CEJ.0b013e3282b71f0d.","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"716_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12094-011-0673-2","volume":"13","author":"MJ Safont","year":"2011","unstructured":"Safont MJ, Gil M, Sirera R, Jantus-Lewintre E, Sanmartin E, Gallach S, Caballero C, Del Pozo N, Palomares E, Camps C: The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression. Clin Transl Oncol. 2011, 13 (6): 396-400. 10.1007\/s12094-011-0673-2.","journal-title":"Clin Transl Oncol"},{"issue":"1\u20132","key":"716_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0304-3835(99)00103-2","volume":"141","author":"T Ishikawa","year":"1999","unstructured":"Ishikawa T, Kamiyama M, Hisatomi H, Ichikawa Y, Momiyama N, Hamaguchi Y, Hasegawa S, Narita T, Shimada H: Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells. Cancer Lett. 1999, 141 (1\u20132): 187-194.","journal-title":"Cancer Lett"},{"issue":"5","key":"716_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1179\/joc.2009.21.5.542","volume":"21","author":"V Smith","year":"2009","unstructured":"Smith V, Dai F, Spitz M, Peters GJ, Fiebig HH, Hussain A, Burger AM: Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents. J Chemother. 2009, 21 (5): 542-549.","journal-title":"J Chemother"},{"issue":"1\u20132","key":"716_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65 (1\u20132): 55-63.","journal-title":"J Immunol Methods"},{"issue":"2","key":"716_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/1096-9098(200006)74:2<141::AID-JSO12>3.0.CO;2-X","volume":"74","author":"T Suzuki","year":"2000","unstructured":"Suzuki T, Ochiai T, Nakajima K, Matsubara H, Arima M, Hori S, Hayashi H, Shimada H, Takeda A, Yanagawa T, Sen K: A feasibility study of chemosensitivity assay by adhesive tumor cell culture system using biopsy specimens for gastric cancer. J Surg Oncol. 2000, 74 (2): 141-147. 10.1002\/1096-9098(200006)74:2<141::AID-JSO12>3.0.CO;2-X.","journal-title":"J Surg Oncol"},{"issue":"5\u20136","key":"716_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2298\/SARH1206305A","volume":"140","author":"Z Andric","year":"2012","unstructured":"Andric Z, Randjelovic T, Kovcin V, Gutovic J, Crevar S, Murtezani Z, Kostic S: Evaluation of the efficacy and toxicity of protocol cisplatin, 5-fluorouracil, leucovorin compared to protocol fluorouracil, doxorubicin and mitomycin C in locally advanced and metastatic gastric cancer. Srp Arh Celok Lek. 2012, 140 (5\u20136): 305-312.","journal-title":"Srp Arh Celok Lek"},{"issue":"2","key":"716_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10120-009-0505-z","volume":"12","author":"J Sakamoto","year":"2009","unstructured":"Sakamoto J, Matsui T, Kodera Y: Paclitaxel chemotherapy for the treatment of gastric cancer. Gastric Cancer. 2009, 12 (2): 69-78. 10.1007\/s10120-009-0505-z.","journal-title":"Gastric Cancer"},{"issue":"4","key":"716_CR27","first-page":"240","volume":"2","author":"P Jimenez","year":"2011","unstructured":"Jimenez P, Pathak A, Phan AT: The role of taxanes in the management of gastroesphageal cancer. J Gastrointest Oncol. 2011, 2 (4): 240-249.","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"716_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/CAD.0b013e3282f46ad8","volume":"19","author":"SH Park","year":"2008","unstructured":"Park SH, Kim YS, Hong J, Park J, Nam E, Cho EK, Shin DB, Lee JH, Lee WK, Chung M: Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study. Anticancer Drugs. 2008, 19 (3): 303-307. 10.1097\/CAD.0b013e3282f46ad8.","journal-title":"Anticancer Drugs"},{"issue":"4","key":"716_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.onc.1205163","volume":"21","author":"S Kyo","year":"2002","unstructured":"Kyo S, Inoue M: Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?. Oncogene. 2002, 21 (4): 688-697. 10.1038\/sj.onc.1205163.","journal-title":"Oncogene"},{"issue":"15","key":"716_CR30","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1096\/fasebj.13.15.2091","volume":"13","author":"JP Liu","year":"1999","unstructured":"Liu JP: Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 1999, 13 (15): 2091-2104.","journal-title":"FASEB J"},{"issue":"1\u20132","key":"716_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2007.10.018","volume":"260","author":"W Li","year":"2008","unstructured":"Li W, Li L, Liu Z, Liu C, Straat K, Bjorkholm M, Jia J, Xu D: Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues. Cancer Lett. 2008, 260 (1\u20132): 28-36.","journal-title":"Cancer Lett"},{"issue":"1","key":"716_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1383-5742(99)00091-5","volume":"462","author":"C Cerni","year":"2000","unstructured":"Cerni C: Telomeres, telomerase, and myc. An update. Mutat Res. 2000, 462 (1): 31-47. 10.1016\/S1383-5742(99)00091-5.","journal-title":"An update. Mutat Res"},{"issue":"3","key":"716_CR33","first-page":"202","volume":"30","author":"V Sakin","year":"2008","unstructured":"Sakin V, Eskiocak U, Kars MD, Iseri OD, Gunduz U: hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells. Exp Oncol. 2008, 30 (3): 202-205.","journal-title":"Exp Oncol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-8-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1746-1596-8-33\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-8-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:20:22Z","timestamp":1630534822000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-8-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,22]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-8-33","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,22]]},"assertion":[{"value":"20 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}